Alzheimer's disease, women, and estrogen replacement therapy

Contemporary Ob-Gyn

Volumn 44, Issue 5, 1999, Pages 110-127

  Paganini Hill, Annlia ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042553321     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Van Duijn CM. Epidemiology of the dementias: recent developments and new approaches. Neuroepidemiology. 1996;60:478-488.
2. Thal U, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology. 1988;38:1083-1090.
3. Buckwalter JG, Sorbel E, Dunn ME, et al. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol. 1993;50:757-760.
4. Henderson VW, Buckwalter JG. Cognitive deficits of men and women with Alzheimer's disease. Neurology. 1994;44:90-96.
5. Ripich DN, Petrill SA, Whitehouse PJ, et al. Gender differences in language of AD patients: a longitudinal study. Neurology. 1995;45:299-302.
6. Cohen D, Eisdorfer C, Gorelick P, et al. Sex differences in the psychiatric manifestations of Alzheimer's disease. J Am Geriatr Soc. 1993;41:229-232.
7. Hyman BT, van Hoesen GW, Damasio AR, et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 1984;225:1168-1170.
8. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983;219:1184-1190.
9. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-479.
10. Evans DA, Funkenstein H, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. J Am Med Assoc. 1989;262:2551-2556.
11. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
12. Rogers SL, Friedhoff LT, Group DS. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, doubleblind, placebo-controlled trial. Dementia. 1996;7:293-303.
13. Sano M, Emesto C, Thomas RG, et al. A controlled trial of selegiline, alphatocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 1997;336:1216-1222.
14. Paganini-Hill A. Does estrogen replacement therapy protect against Alzheimer's disease? Osteoporosis Int. 1997;7(suppl 1):S12-S17.
15. Honjo H, Ogino Y, Tanaka K, et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled double blind study. J Jpn Menopause Soc. 1993;1:167-171.
16. Asthana S, Craft S, Baker LD, et al. Transdermal estrogen improves memory in women with Alzheimer's disease (abstract). Soc Neurosci Abstr. 1996;22:200.
17. Birge SJ. The role of estrogen in the treatment of Alzheimer's disease. Neurology. 1997;48(suppl 7):S36-S41.
18. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med. 1996;156:2213-2217.
19. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based, case-control study. Am J Epidemiol. 1994;140:262-267.
20. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429-432.
21. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517-1521.
22. Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 1994;51:896-900.
23. Mortel KF, Metyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. Neuropsychiatry Clin Neurosci. 1995;7:334-337.
24. Lerner A, Cole R, Debanne S, et al. Immunological and endocrine conditions in an Alzheimer's disease case-control study (abstract). Neuroepidemiology. 1995;14:307.
25. Waring SC, Rocca WA, Petersen RC, et al. Postmenopausal estrogen replacement therapy and Alzhemer's disease: a population-based study in Rochester, Minnesota (abstract). Neurology. 1997;48 (Suppl 2):A79.
26. Baldereschi M, DiCarlo A, Lepore V. Estrogen replacement therapy and Alzhemer's disease in the Italian longitudinal study on aging. Neurology. 1998;50:996-1002.